Blood Gas Monitoring Market Growing Steadily
Blood gas monitoring involves an estimation of the level of oxygen and carbon dioxide in the blood and the pH of blood. Traditionally, blood gas estimations were performed by drawing a sample of blood and then sending it to a central laboratory for proper analysis. With this procedure comes the ever-present danger of possible errors resulting from storage, transportation , and the actual time lapse between sampling and testing.
According to new research fromFrost & Sullivan, the U.S. Blood Gas Monitoring Markets generated more than $156 million in revenues in 1999, and the market is projected to reach $176.8 million by 2006 with a modest compound annual growth rate.
These new methods of testing, which include invasive and noninvasive techniques, give doctors instant, reliable results when monitoring of a patients' blood gas is needed, rather than a full test.
Noninvasive monitors, including pulse oximetry and transcutaneous monitors, have improved with better technology and give physicians more reliable data. This segment makes up a majority of revenues in the overall gas monitoring market, totaling $120.9 million in revenues in 1999.
"Technological advances that lead to increasing accuracy and reliability of results are generating greater confidence in the use of pulse oximeters, stimulating sales," say Frost & Sullivan analysts Minal Vasanawala and Mahpara Qureshi. "Transcutaneous monitors are increasingly tailored to meet physician needs with quick calibration and re-membraning procedures, easy snap on application, site timers, and more durable electrode technology."
New technologies are also allowing invasive techniques to get quick, reliable data, driving this segment just a bit faster than the rest of the market. Portable, compact, and handheld blood gas analyzers allow doctors to do a thorough blood analysis at the point of care.
"Easy-to-use disposable cartridges avoid contamination and decrease handling of biohazardous material, and turnaround times of less than two minutes have made these point-of-care blood gas analyzers a standard in the care of the critically ill," say Vasanawala and Qureshi.
This blood gas monitoring industry research has integrated the market engineering consulting philosophy into the entire research process. Critical phases of this research included: identification of industry challenges, market engineering measurements, strategic recommendations, planning, and market monitoring. All of the vital elements of this system help the market participants navigate successfully through the world medical testing and monitoring equipment markets.
The report is available for $3,450.
For more information: Erika Brown, Frost & Sullivan, 90 West St., Suite #1301, New York, NY 10006. Tel: 212-964-7000, ext. 225. Fax: 212-619-0831. Or visit the company's Storefront on Medical Design Online.